Abacavir

In the US, Abacavir (abacavir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

• Abacavir


• Abacavir Solution


• Abacavir/Lamivudine


• Abacavir/Lamivudine/Zidovudine


• Abacavir and lamivudine


• Abacavir, lamivudine, and zidovudine


• Abacavir-lamivudine-zidovudine


• Abacavir Sulfate


• Abacavir Sulfate/Lamivudine


• Abacavir Sulfate/Lamivudine/Zidovudine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF06

CAS registry number (Chemical Abstracts Service)

0136470-78-5

Chemical Formula

C14-H18-N6-O

Molecular Weight

286

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Names

(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol (WHO)

(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-methanol (IUPAC)

2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-

Foreign Names

• Abacavirum (Latin)
• Abacavir (German)
• Abacavir (French)
• Abacavir (Spanish)

Generic Names

• Abacavir (OS: BAN, DCF)
• Abacavir Sulfate (OS: USAN)
• Abacavir Sulphate (2:1) (OS: BANM)
• 1592 U 89 sulfate (IS: GlaxoWellcome)
• Abacavir Sulfate (PH: Ph. Int. 4)

Brand Names

• Abacavir Elea
  Elea, Argentina



• Endocare
  Farmacare, Peru



• Kivexa (Abacavir and Lamivudine)
  Glaxo Group, Austria; GlaxoSmithKline, Slovenia



• Trizivir
  GlaxoSmithKline, Czech Republic



• Trizivir (Abacavir and Lamivudine, + Zidovudine)
  Glaxo SmithKline, Spain



• Ziagen
  Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Colombia; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Peru; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa



• Abamune
  Biotoscana, Colombia; Cipla, India



• Epzicom (Abacavir and Lamivudine)
  GlaxoSmithKline, Japan; ViiV Healthcare, United States



• Filabac
  Filaxis, Argentina



• Kivexa (Abacavir and Lamivudine)
  Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Portugal; GlaxoSmithKline, Sweden; GlaxoSmithKline, South Africa; ViiV, Switzerland



• Plusabcir
  Dosa, Argentina



• Trizivir (Abacavir and Lamivudine, + Zidovudine)
  Glaxo Group, Austria; Glaxo Wellcome, Bulgaria; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Ireland; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, South Africa; Shire, Canada; ViiV, Switzerland; ViiV Healthcare, United States



• Zepril
  Richmond, Argentina



• Ziagen
  Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; Glaxo Wellcome, Slovenia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Venezuela; ViiV, Switzerland; ViiV Healthcare, United States



• Ziagenavir
  GlaxoSmithKline, Argentina; GlaxoSmithKline, Brazil; GlaxoSmithKline, Mexico; GlaxoSmithKline, Thailand

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.